Back to top
more

AdaptHealth (AHCO)

(Delayed Data from NSDQ)

$8.91 USD

8.91
1,006,730

-0.31 (-3.36%)

Updated Sep 17, 2025 04:00 PM ET

After-Market: $8.90 -0.01 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (87 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

AdaptHealth Corp. (AHCO) Q2 Earnings and Revenues Miss Estimates

by Zacks Equity Research

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -35.71% and 0.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AdaptHealth Corp. (AHCO) Surges 8.3%: Is This an Indication of Further Gains?

by Zacks Equity Research

AdaptHealth Corp. (AHCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

CytoSorbents (CTSO) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

CytoSorbents (CTSO) delivered earnings and revenue surprises of -78.57% and 11.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Baxter (BAX) delivered earnings and revenue surprises of -1.14% and 3.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AdaptHealth Corp. (AHCO) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -109.52% and 9.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Akerna Corp. (KERN) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Akerna Corp. (KERN) delivered earnings and revenue surprises of -17.65% and 16.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Boston Scientific (BSX) Tops Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Boston Scientific (BSX) delivered earnings and revenue surprises of 2.63% and 2.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AdaptHealth Corp. (AHCO) Q4 Earnings Miss Estimates

by Zacks Equity Research

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -62.50% and 1.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AdaptHealth Corp. (AHCO) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

AdaptHealth Corp. (AHCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

AdaptHealth Corp. (AHCO) Moves 5.8% Higher: Will This Strength Last?

by Zacks Equity Research

AdaptHealth Corp. (AHCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Are Investors Undervaluing These Medical Stocks Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Phillips (PHG) Blends 3D Mapping With Zenition, Aids Prospects

by Zacks Equity Research

Phillips (PHG) integrates AI and 3D mapping capabilities it its Mobile C-Arm System, Zenition, enhancing its diagnostic imaging portfolio.

Zacks Equity Research

Are Investors Undervaluing These Medical Stocks Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

AdaptHealth Corp. (AHCO) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

AdaptHealth Corp. (AHCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

AHCO vs. LMAT: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

AHCO vs. LMAT: Which Stock Is the Better Value Option?

Zacks Equity Research

AHCO vs. SYK: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

AHCO vs. SYK: Which Stock Is the Better Value Option?

Kinjel Shah headshot

5 Valuable Price-to-Book Stocks to Add to Your Portfolio

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks that have high-growth prospects. ASE Technology Holding (ASX), AdaptHealth Corp. (AHCO), ICL Group (ICL), Conn's (CONN) and Atlas Corp. (ATCO) are some such picks.

Zacks Equity Research

Can AdaptHealth (AHCO) Stock Continue to Grow Earnings?

by Zacks Equity Research

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider AdaptHealth (AHCO).

Zacks Equity Research

Does AdaptHealth Corp. (AHCO) Have the Potential to Rally 60% as Wall Street Analysts Expect?

by Zacks Equity Research

The mean of analysts' price targets for AdaptHealth Corp. (AHCO) points to a 60% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

AHCO or PETQ: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

AHCO vs. PETQ: Which Stock Is the Better Value Option?

Zacks Equity Research

AdaptHealth Corp. (AHCO) Q3 Earnings Miss Estimates

by Zacks Equity Research

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -41.18% and 2.52%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AdaptHealth Corp. (AHCO) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

AdaptHealth Corp. (AHCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

AdaptHealth Corp. (AHCO) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -137.93% and 7.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

AdaptHealth Corp. (AHCO) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

AdaptHealth Corp. (AHCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

AdaptHealth Corp. (AHCO) Lags Q1 Earnings and Revenue Estimates

by Zacks Equity Research

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -29.17% and -0.57%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?